New York, February 26, 2018:

    Human Insulin Drugs & Delivery Devices Market 2018

    The Global Human Insulin Drugs & Delivery Devices Market is expected to exceed more than US$ 45.00 Billion by 2022 at a CAGR of 8.00% in the given forecast period.

    The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market.

    Key players profiled in the report include Eli Lilly and Company (U.S.), Biocon Ltd. (India), Julphar (U.A.E.), Sanofi (France), Ypsomed AG (Switzerland), Becton, Dickinson and Company (U.S.), Wockhardt Ltd. (India). Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

    You can browse full report here:

    The Global Human insulin Drugs & Delivery Market has been segmented as below:

    By Product Analysis:

    • HI Drugs
    • HI Delivery Devices

    By Drug Analysis:

    • Insulin Analogs & Biosimilars
    • HI Biologics

    By Delivery Devices Analysis:

    • Syringes
    • Pens
    • Pen Needles

    By Regional Analysis:

    • North America
    • Europe
    • Asia-Pacific
    • Rest of the World

    The major driving factors of Global Human Insulin Drugs & Delivery Devices Market As follows:

    • Increase in Diabetic patient population
    • Rising market demand for Insulin drugs
    • Technological advancement of Insulin drugs
    • Proper reimbursement policy in developed countries

    The restraining factors of ­Global Insulin Drugs & Delivery Devices Market as follows:

    • High Manufacturing cost
    • Increase in the population exposure
    • Stringent regulatory reforms for product sanction

    This report provides:

    1) An overview of the global market for Insulin Drugs & Delivery Devices.
    2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022
    3) Identifications of new market opportunities and targeted promotional plans for Global Insulin Drugs & Delivery Devices Market
    4) Discussion of research and development, and the demand for new products and new applications.
    5) Comprehensive company profiles of major players in the industry.

    Reasons to Buy this Report:

    1) Obtain the most up to date information available on all Global Human Insulin Drugs & Delivery Devices Market.
    2) Identify growth segments and opportunities in the industry.
    3) Facilitate decision making on the basis of strong historic and forecast of Global Human Insulin Drugs & Delivery Devices Market data.
    4) Assess your competitor’s refining portfolio and its evolution.

    Request Sample Report:


    Table of Contents


    2 Research Methodology

    3 Executive Summary

    4 Premium Insights

    5 Market Overview

    6 Industry Insights

    6.1 Introduction
    6.2 Industry Trends
    6.2.1 Growing Market Demand for HI Pens
    6.2.2 Increasing Market Focus on the Pipeline Development of Novel Human Insulin Therapies
    6.3 Pipeline Analysis
    6.3.1 By Company
    6.3.2 By Clinical Trial Phase
    6.3.3 Porter’s Five Force Analysis Threat From New Entrants Threat From Substitutes Bargaining Power of Buyers Bargaining Power of Suppliers Intensity of Competitive Rivalry

    7 Global Human Insulin Market, By Product Type

    8 Global Human Insulin Drugs Market, By Type

    9 Global Human Insulin Drugs Market, By Brand

    10 Global Human Insulin Market, By Delivery Devices

    11 Global Human Insulin Market, By Application

    12 Human Insulin Market, By Region

    13 Competitive Landscape

    14 Company Profiles

    14.1 Introduction

    14.2 B. Braun Melsungen AG

    14.3 Becton, Dickinson and Company

    14.4 Biocon Limited

    14.5 Biodel Inc.

    14.6 ELI Lilly and Company

    14.7 Julphar

    14.8 NOVO Nordisk A/S

    14.9 Sanofi

    14.10 Wockhardt Limited

    14.11 Ypsomed AG


    Media Contact

    Company Name: Market Research Engine

    Contact Person: John Bay


    Phone: +1-855-984-1862

    Country: United States